Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". Scope of the Report: This report focuses on the Paclitaxel in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Phyton ScinoPharm Novasep Samyang Polymed TAPI (Teva) Fresenius-kabi Southpharma Haiyao Huiang biopharma Yunnan Hande Hainan Yew Pharm Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Natural Paclitaxel Semi-synthetic Paclitaxel Market Segment by Applications, can be divided into Ovarian Cancer Cervical Cancer Breast Cancer Other There are 15 Chapters to deeply display the North America Paclitaxel market. Chapter 1, to describe Paclitaxel Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Paclitaxel, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Paclitaxel, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Paclitaxel market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Paclitaxel Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Paclitaxel Introduction 1.2 Market Analysis by Type 1.2.1 Natural Paclitaxel 1.2.2 Semi-synthetic Paclitaxel 1.3 Market Analysis by Applications 1.3.1 Ovarian Cancer 1.3.2 Cervical Cancer 1.3.3 Breast Cancer 1.3.4 Other 1.4 Market Analysis by Countries 1.4.1 United States Sta
